Pesquisa | BVS Doenças Infecciosas e Parasitárias

1.

Nitric Oxide-Releasing Macromolecule Exhibits Broad-Spectrum Antifungal Activity and Utility as a Topical Treatment for Superficial Fungal Infections.

Stasko, Nathan; McHale, Kimberly; Hollenbach, Stanley J; Martin, Megan; Doxey, Ryan.

Antimicrob Agents Chemother ; 62(7)2018 07.

Artigo em Inglês | MEDLINE | ID: mdl-29760128

2.

A Phase 2 Controlled Study of SB206, a Topical Nitric Oxide-Releasing Drug for Extragenital Wart Treatment.

Tyring, Stephen K; Rosen, Theodore; Berman, Brian; Stasko, Nathan; Durham, Todd; Maeda-Chubachi, Tomoko.

J Drugs Dermatol ; 17(10): 1100-1105, 2018 Oct 01.

Artigo em Inglês | MEDLINE | ID: mdl-30365591

3.

A Phase 2, Controlled, Dose-Ranging Study of SB208, an Investigational Topical Nitric Oxide-Releasing Drug, for the Treatment of Tinea Pedis.

Elewski, Boni E; Kircik, Leon H; Stasko, Nathan; De Leon, Emily; Enloe, Carolyn; Durham, Todd; Maeda-Chubachi, Tomoko.

J Drugs Dermatol ; 17(8): 888-893, 2018 Aug 01.

Artigo em Inglês | MEDLINE | ID: mdl-30124729

4.

Efficacy and hazards of 425 nm oral cavity light dosing to inactivate SARS-CoV-2.

Stockslager, Max A; Kocher, Jacob F; Arwood, Leslee; Stasko, Nathan; McDonald, Rebecca A; Tapsak, Mark A; Emerson, David.

J Dent ; 123: 104203, 2022 08.

Artigo em Inglês | MEDLINE | ID: mdl-35724941

5.

Visible blue light inactivates SARS-CoV-2 variants and inhibits Delta replication in differentiated human airway epithelia.

Kocher, Jacob; Arwood, Leslee; Roberts, Rachel C; Henson, Ibrahim; Annas, Abigail; Emerson, David; Stasko, Nathan; Fulcher, M Leslie; Brotton, Marisa; Randell, Scott H; Cockrell, Adam S.

bioRxiv ; 2022 Jan 31.

Artigo em Inglês | MEDLINE | ID: mdl-35132416

6.

Economic and clinical impact of a novel, light-based, at-home antiviral treatment on mild-to-moderate COVID-19.

Gibson, Scott; Saunders, Rhodri; Stasko, Nathan; Bickerstaff, Cherrishe-Brown; Oakley, John; Osterman, Mark; Torres, Rafael Torrejon; Kish, Jonathan K; Feinberg, Bruce A; Emerson, David.

J Med Econ ; 25(1): 503-514, 2022.

Artigo em Inglês | MEDLINE | ID: mdl-35387539

7.

A randomized, controlled, feasibility study of RD-X19 in subjects with mild-to-moderate COVID-19 in the outpatient setting.

Stasko, Nathan; Cockrell, Adam S; Kocher, Jacob F; Henson, Ibrahim; Emerson, David; Wang, Ye; Smith, Jonathan R; Henderson, Nathan H; Wood, Hillary; Bradrick, Shelton S; Jones, Terry; Santander, Jorge; McNeil, John G.

Clin Transl Sci ; 15(5): 1291-1303, 2022 05.

Artigo em Inglês | MEDLINE | ID: mdl-35137532

8.

Visible blue light inhibits infection and replication of SARS-CoV-2 at doses that are well-tolerated by human respiratory tissue.

Stasko, Nathan; Kocher, Jacob F; Annas, Abigail; Henson, Ibrahim; Seitz, Theresa S; Miller, Joy M; Arwood, Leslee; Roberts, Rachel C; Womble, Thomas M; Keller, Emily G; Emerson, Soren; Bergmann, Michael; Sheesley, Ashley N Y; Strong, Rebecca J; Hurst, Brett L; Emerson, David; Tarbet, E Bart; Bradrick, Shelton S; Cockrell, Adam S.

Sci Rep ; 11(1): 20595, 2021 10 18.

Artigo em Inglês | MEDLINE | ID: mdl-34663881

9.

Reduced ischemia/reperfusion injury via glutathione-initiated nitric oxide-releasing dendrimers.

Johnson, Timothy A; Stasko, Nathan A; Matthews, Jessica L; Cascio, Wayne E; Holmuhamedov, Ekhson L; Johnson, C Bryce; Schoenfisch, Mark H.

Nitric Oxide ; 22(1): 30-6, 2010 Jan 01.

Artigo em Inglês | MEDLINE | ID: mdl-19914388

10.

S-nitrosothiol-modified dendrimers as nitric oxide delivery vehicles.

Stasko, Nathan A; Fischer, Thomas H; Schoenfisch, Mark H.

Biomacromolecules ; 9(3): 834-41, 2008 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-18247567

11.

Influence of glutathione and its derivatives on fibrin polymerization.

Geer, Carri B; Stasko, Nathan A; Rus, Ioana A; Lord, Susan T; Schoenfisch, Mark H.

Biomacromolecules ; 9(7): 1876-82, 2008 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-18570468

12.

Cytotoxicity of polypropylenimine dendrimer conjugates on cultured endothelial cells.

Stasko, Nathan A; Johnson, C Bryce; Schoenfisch, Mark H; Johnson, Timothy A; Holmuhamedov, Ekhson L.

Biomacromolecules ; 8(12): 3853-9, 2007 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-18004811

13.

Results of a Phase 2 Efficacy and Safety Study with SB204, an Investigational Topical Nitric Oxide-releasing Drug for the Treatment of Acne Vulgaris.

Baldwin, Hilary; Blanco, Daisy; McKeever, Charles; Paz, Nelly; Vasquez, Ynca Nina; Quiring, John; Enloe, Carolyn; De León, Emily; Stasko, Nathan.

J Clin Aesthet Dermatol ; 9(8): 12-8, 2016 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-27672413

14.

Bactericidal efficacy of nitric oxide-releasing silica nanoparticles.

Hetrick, Evan M; Shin, Jae Ho; Stasko, Nathan A; Johnson, C Bryce; Wespe, Daniel A; Holmuhamedov, Ekhson; Schoenfisch, Mark H.

ACS Nano ; 2(2): 235-46, 2008 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-19206623

15.

Water-soluble nitric oxide-releasing gold nanoparticles.

Polizzi, Mark A; Stasko, Nathan A; Schoenfisch, Mark H.

Langmuir ; 23(9): 4938-43, 2007 Apr 24.

Artigo em Inglês | MEDLINE | ID: mdl-17375944

16.

Dendrimers as a scaffold for nitric oxide release.

Stasko, Nathan A; Schoenfisch, Mark H.

J Am Chem Soc ; 128(25): 8265-71, 2006 Jun 28.

Artigo em Inglês | MEDLINE | ID: mdl-16787091

BVS Doenças Infecciosas e Parasitárias

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar: